Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis
Nossent, H.
Journal of Rheumatology 27(9): 2282-2283
2000
ISSN/ISBN: 0315-162X PMID: 10990252 Document Number: 525085
Document emailed within 1 workday
Related Documents
Gonzalez-Gay, M.A.; Llorca, J.; Palomino-Morales, R.; Gomez-Acebo, I.; Gonzalez-Juanatey, C.; Martin, J. 2009: Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis Clinical and Experimental Rheumatology 27(1): 116-119Haye Salinas, M.ía.J.; Bertoli, A.M.; Lema, L.; Saucedo, C.; Rosa, J.; Quintana, R.; Bellomio, V.ón.; Aguero, S.; Spindler, W.; Tamborenea, M.ía.N.; Schimid, M.; Ceccato, F.; Sala, J.é P.; Paira, S.; Spindler, A.; Soriano, E.R.; Estel, B.A.P.; Caeiro, F.; Alvarellos, A.; Saurit, V.ón. 2013: Prevalence of dyslipidemia and elevated cardiovascular risk in patients with rheumatoid arthritis Medicina 73(1): 26-30
Thomas, S. 2011: Determining cardiovascular risk in patients with rheumatoid arthritis: prove the efficacy of interventions first NederlandsTijdschriftVoorGeneeskunde 155(30-31):A3563
Santos, M.J.é; Vinagre, F.; Silva, J.é J.é; Gil, V.; Fonseca, J.ão.E. 2010: Cardiovascular risk profile in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of female patients Acta Reumatologica Portuguesa 35(3): 325-332
García-Bermúdez, M.; González-Juanatey, C.; Rodríguez-Rodríguez, L.; Miranda-Filloy, J.A.; Perez-Esteban, S.; Vazquez-Rodriguez, T.R.; Castañeda, S.; Balsa, A.; Fernández-Gutierrez, B.; Llorca, J.; González-Alvaro, I.; Martín, J.; González-Gay, M.A. 2011: Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 29(4): 681-688
Chen, Y.; Wang, J.; An, Y.; Gong, Q.; He, Y.; Zhang, B.; Li, H.; Shuai, Y.; Tang, X.; Jiang, Y.; Hong, J.; Yang, W.; Hu, Y.; Li, G. 2015: Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study Zhonghua Nei Ke Za Zhi 54(1): 13-17
Rosales-Alexander, J.L.; Salvatierra, J.; Llorca, J.; Magro-Checa, C.; González-Gay, M.A.; Cantero-Hinojosa, J.; Raya-Álvarez, E. 2014: Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index Clinical and Experimental Rheumatology 32(2): 237-242
Fujibayashi, T.; Tamura, Y.; Tsuboi, S.; Miyake, N.; Saitoh, S. 2001: Evaluation of cerebrovascular events in patients with rheumatoid arthritis Ryumachi 41(1): 3-8
Rebrov, A.P.; Nikitina, N.M.; Gaĭdukova, I.Z. 2011: Cardiovascular risk factors in psoriatic and rheumatoid arthritis Terapevticheskii Arkhiv 83(5): 20-24
McCarey, D.; Sturrock, R.D. 2009: Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis Clinical and Experimental Rheumatology 27(4 Suppl 55: S124-S126
Krause, D.; Gabriel, B.; Herborn, G.; Braun, J.; Rau, R. 2014: The positive influence of methotrexate on the mortality of patients with rheumatoid arthritis is partly independent of its effect on disease activity: results of a re-evaluation 18 years after baseline Clinical and Experimental Rheumatology 32(3): 395-400
Jiang, L.; Zhao, N.; Ni, L. 2002: Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs Zhonghua Liu Xing Bing Xue Za Zhi 23(3): 213-217
Cleland, L.G.; Caughey, G.E.; James, M.J.; Proudman, S.M. 2006: Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis Journal of Rheumatology 33(10): 1973-1979
Protopopova, D.; Masopust, J.; Maly, R.; Valis, M.; Bazant, J. 2012: The prevalence of cardiometabolic risk factors and the ten-year risk of fatal cardiovascular events in patients with schizophrenia and related psychotic disorders Psychiatria Danubina 24(3): 307-313
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Fries, J.F.; Bruce, B. 2003: Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis Journal of Rheumatology 30(10): 2226-2233
Gonzalez-Gay, M.A.; Llorca, J.; Garcia-Unzueta, M.T.; Gonzalez-Juanatey, C.; De Matias, J.M.; Martin, J.; Redelinghuys, M.; Woodiwiss, A.J.; Norton, G.R.; Dessein, P.H. 2008: High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis Clinical and Experimental Rheumatology 26(4): 596-603
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094
Soejima, M.; Kawaguchi, Y.; Hara, M.; Kamatani, N. 2008: Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis Journal of Rheumatology 35(4): 724
Maslova, I.M. 2008: Antihypertensive therapy substantially lowers mortality and rate of cardiovascular events in patients aged 80 years and older Kardiologiia 48(8): 73-74